Edward H Myles
CIK 1358219 · COO & CFO · last filed 2025-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.08M
Companies
4
Total Filings
41
Lifetime Open-Market Net
-$16.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | COO & CFO | 205,552 | $44.18 | $9.08M | -$16.81M | 24 | 2025-03-12 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | COO & CFO | 98,659 | — | — | $0 | 12 | 2020-03-12 |
| Ocata Therapeutics, Inc. (OCAT) Delisted | COO & CFO | 0 | — | — | $0 | 1 | 2016-02-11 |
| PRESSURE BIOSCIENCES INC (PBIO) Delisted | Senior VP of Finance & CFO | — | — | — | $0 | 1 | 2008-09-29 |
Recent Filings · Page 3 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-17 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2020-03-12 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2020-03-04 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,021 | -$7.9K | EDGAR |
| 2020-02-25 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −2,253 | -$20.5K | EDGAR |
| 2019-05-23 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2019-04-12 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,964 | -$24.5K | EDGAR |
| 2019-03-05 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,064 | -$15.7K | EDGAR |
| 2019-02-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +32,000 | $0 | EDGAR |
| 2019-02-26 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −869 | -$13.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.